Found: 26
Select item for more details and to access through your institution.
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information.
- Published in:
- PLoS ONE, 2024, v. 19, n. 2, p. 1, doi. 10.1371/journal.pone.0299487
- By:
- Publication type:
- Article
Time to onset of antifracture efficacy and year-by-year persistence of effect of zoledronic acid in women with osteoporosis.
- Published in:
- Journal of Bone & Mineral Research, 2012, v. 27, n. 7, p. 1487, doi. 10.1002/jbmr.1605
- By:
- Publication type:
- Article
Effects of antiresorptive treatment on nonvertebral fracture outcomes.
- Published in:
- Journal of Bone & Mineral Research, 2011, v. 26, n. 10, p. 2411, doi. 10.1002/jbmr.446
- By:
- Publication type:
- Article
Once-yearly zoledronic acid and days of disability, bed rest, and back pain: Randomized, controlled HORIZON Pivotal Fracture Trial.
- Published in:
- Journal of Bone & Mineral Research, 2011, v. 26, n. 5, p. 984, doi. 10.1002/jbmr.292
- By:
- Publication type:
- Article
Efficacy and Safety of a Once-Yearly i.v. Infusion of Zoledronic Acid 5 mg Versus a Once-Weekly 70-mg Oral Alendronate in the Treatment of Male Osteoporosis: A Randomized, Multicenter, Double-Blind, Active-Controlled Study.
- Published in:
- Journal of Bone & Mineral Research, 2010, v. 25, n. 10, p. 2239, doi. 10.1002/jbmr.119
- By:
- Publication type:
- Article
Potential Mediators of the Mortality Reduction With Zoledronic Acid After Hip Fracture.
- Published in:
- Journal of Bone & Mineral Research, 2010, v. 25, n. 1, p. 91, doi. 10.1359/jbmr.090704
- By:
- Publication type:
- Article
Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis.
- Published in:
- Journal of Bone & Mineral Research, 2009, v. 24, n. 9, p. 1544, doi. 10.1359/JBMR.090310
- By:
- Publication type:
- Article
Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture.
- Published in:
- Journal of Bone & Mineral Research, 2009, v. 24, n. 7, p. 1308, doi. 10.1359/JBMR.090209
- By:
- Publication type:
- Article
Effects of Intravenous Zoledronic Acid Once Yearly on Bone Remodeling and Bone Structure.
- Published in:
- Journal of Bone & Mineral Research, 2008, v. 23, n. 1, p. 6, doi. 10.1359/JBMR.070906
- By:
- Publication type:
- Article
Developing generic templates to shape the future for conducting integrated research platform trials.
- Published in:
- Trials, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s13063-024-08034-8
- By:
- Publication type:
- Article
Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Decision rules for identifying combination therapies in open‐entry, randomized controlled platform trials.
- Published in:
- Pharmaceutical Statistics, 2022, v. 21, n. 3, p. 671, doi. 10.1002/pst.2194
- By:
- Publication type:
- Article
Systematic review of available software for multi-arm multi-stage and platform clinical trial design.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effects of oxcarbazepine on sodium concentration and water handling.
- Published in:
- Annals of Neurology, 2002, v. 51, n. 5, p. 613, doi. 10.1002/ana.10190
- By:
- Publication type:
- Article
Regulatory Issues of Platform Trials: Learnings from EU‐PEARL.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 1, p. 52, doi. 10.1002/cpt.3244
- By:
- Publication type:
- Article
Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints.
- Published in:
- PLoS ONE, 2023, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0281674
- By:
- Publication type:
- Article
Poster 54: Impact of Zoledronic Acid on Change in Charlson Co‐morbidity Index Score and its Relationship With Mortality in Patients With Recent Hip Fracture.
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Poster 43: Effect of Intravenous Zoledronic Acid on Lumbar Spine Bone Mineral Density Compared to Oral Risedronate in Subgroups of Patients Receiving Glucocorticoid Therapy.
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Poster 42: Effect of a Single Intravenous Infusion of Zoledronic Acid on Bone Turnover Markers Compared to Oral Risedronate Over 1 Year in Patients with Glucocorticoid‐Induced Osteoporosis.
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Poster 42: Effect of a Single Intravenous Infusion of Zoledronic Acid on Bone Turnover Markers Compared to Oral Risedronate Over 1 Year in Patients with Glucocorticoid-Induced Osteoporosis
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Poster 54: Impact of Zoledronic Acid on Change in Charlson Co-morbidity Index Score and its Relationship With Mortality in Patients With Recent Hip Fracture
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Poster 43: Effect of Intravenous Zoledronic Acid on Lumbar Spine Bone Mineral Density Compared to Oral Risedronate in Subgroups of Patients Receiving Glucocorticoid Therapy
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture.
- Published in:
- Journal of Bone & Mineral Research, 2014, v. 29, n. 12, p. 2545, doi. 10.1002/jbmr.2283
- By:
- Publication type:
- Article
Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal women.
- Published in:
- Kidney International, 2008, v. 74, n. 5, p. 641, doi. 10.1038/ki.2008.193
- By:
- Publication type:
- Article
Efficacy and Safety of a Once-Yearly Intravenous Zoledronic Acid 5 mg for Fracture Prevention in Elderly Postmenopausal Women with Osteoporosis Aged 75 and Older.
- Published in:
- Journal of the American Geriatrics Society, 2010, v. 58, n. 2, p. 292, doi. 10.1111/j.1532-5415.2009.02673.x
- By:
- Publication type:
- Article
On model-based time trend adjustments in platform trials with non-concurrent controls.
- Published in:
- 2022
- By:
- Publication type:
- journal article